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ABSTRACT 
Strategies, Tactics, and Tools to Achieve  
Chemical Syntheses of cis-Clerodane Terpenoids 
Qinda Ye 
The clerodane diterpenoids are a large group of secondary metabolites that display an 
array of biological activities and structural diversity. This dissertation details our efforts to 
synthesize clerodane natural products through a unified design and the use of a key synthetic 
intermediate.  
Thus, Chapter 1 will serve to introduce this unique and interesting class of terpenoids, 
beginning with their proposed biosynthesis. This section will be followed by a highlight of their 
diverse biological activities. Lastly, a select collection of representative total syntheses will be 
described to provide a sense of the state of the art in accessing their molecular complexity. 
Next, Chapter 2 will begin with our design of a two-phase approach towards the 
clerodane family, followed by an introduction of scaparvin A as an excellent example of a target 
with complex architecture and multiple oxygenated functional groups worthy of synthetic and 
biological study. In addtion, a detailed retrosynthetic analysis of scaparvin A will be described 
based on our global strategy for accessing the family.  
Then, we will focus our discussion in Chapter 3 on the efficient construction of the 
common intermediate, while two modes of directed C–H oxidation to deliver the requisite 
oxidation state will be covered in Chapter 4. Finally, efforts of late-stage modification towards 
 
scaparvin A and related compounds will be summarized in Chapter 5, culminating in a near 
complete synthesis of scaparvin A as well as a completed total synthesis of scaparvin C. 
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1.1    Introduction 
The clerodane diterpenoids (general structure 1, Figure 1) are a large group of secondary 
metabolites that have long been known within the scientific community.1 The structure of 
clerodin (2), the inaugural member of the clerodane series, was elucidated by Barton in 1961,2 
and its absolute stereochemistry was revised in 1979.3 In the ensuing decades, over one thousand 
diterpenoids and nor-diterpenoids with the clerodane carbon framework have been separated and 
identified, and these compounds often show a variety of interesting biological activities, 
including antifeedant, antitumor, antifungal, antibiotic, and anti-pepticulcer properties.1a,4  
 
Structurally, most clerodane diterpenoids have four contiguous stereogenic centers on a 
decalin skeleton as shown in 1. This unique structural feature, along with their diverse biological 
activities, have attracted intense synthetic studies and total synthesis efforts.5 Globally, this 
opening chapter will serve to introduce this unique and interesting class of terpenoids, beginning 
3 
 
with their proposed biosynthesis. This section will be followed by a highlight of their diverse 
biological activities. Finally, a select collection of representative total syntheses will be described 
to provide a sense of the state of the art in accessing their molecular complexity. 
 
1.2    Biosynthesis of the Clerodane Terpenoids 
Biosynthetically, the clerodane terpenoids appear to be related to the labdanes via a series 
of methyl and hydride shifts (Scheme 1). The formation of the labdane carbon backbone itself 
can be rationalized by a cyclases-catalyzed cyclization6 of geranylgeranyl diphosphate (10).7 
Sequentially, the labdadienyl cation formed (11) could be converted into naturally occurring 




However, when the rearrangement of labdadienyl cation (11) proceeds in a concerted 
manner up to the shift of 4α-methyl group, clerodane terpenoids with a trans-ring fusion (shown 
as clerodin 2) will be resulted after an oxidase phase. By contrast, the wide occurrence of cis-
clerodanes (shown as fibleucin, 38) suggests the intervention of a stepwise process with a “pause” 
at intermediate 14, which then leads to either cis- or trans- products, dependant upon which of 
the C-4 methyl groups migrates.  
The other variation of relative stereochemistry within the class is associated with the 
stereogenic center at C-8 (Figure 2). In most cases, the C1-unit groups at C-8 and C-9 are cis as 
predicted from the biosynthesis, while a trans configuration exists in a small percentage of the 




Thus, four types of the clerodane carbon skeleton (Figure 2) are distinguished with 
respect to the configuration of ring fusion and the substitution at the C-8 and C-9 positions 
(Types TC, TT, CC, and CT). As for the absolute configuration, the compounds are classified 
into two classes, neo- (as illustrated) and ent-neo-clerodanes (reversed).3 
 
1.3    Biological Activity of the Clerodane Terpenoids  
Only a small percentage of the clerodanes have been reported to exhibit any biological 
activity. However, even fewer members have been shown to have no activity in the tests carried 
out, thus rendering the majority as simply untested or unreported in terms of functional 
properties.1a The reported biological activities range from antifeedant, antitumor, antifungal, and 
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antibiotic to anti-pepticulcer activity.1a,4 In this section, a number of clereodane natural products 
with unique biological activities will be highlighted.  
The insect antifeedant activities of the clerodane diterpenoids is by far the most 
extensively studied biological property,9 with an emphasis placed on the safety aspects of natural 
insect antifeedants in relation to mammalian life. Significant activity is sometimes displayed at 
low concentrations, and more importantly, that activity could be directed specifically against a 
narrow group of insect pests, leaving beneficial insects and other species unharmed. 
 
For instance, of the compounds obtained from the Ajuga genus (Labiatae), ajugarins I-
III10 (5, 16, 17, Figure 3) show antifeedant activity towards the African army worm and African 
desert locust (Schisticerea gregaria), whilst ajugarin IV11 (18) acts as an insecticide against 




Biological evaluation of clerodane terpenoids in the recent decades has revealed many 
compounds with appealing antitumor activities. For example, clerocidin (19)13 and terpentecin 
(20)14, potent antibiotics, also displays impressive antitumor activities involving topoisomerase II 
mediated DNA cleavage.15 Popolohuanone E (7), an oxidatively-dimerized arenarol derivative, 
acts as a potent inhibitor of topoisomerase II, and is also proved to be selectively cytotoxic to 
human non-small cell lung cancer cell line.16 In addition, asmarines A (21) and B (8) have been 
found to have cytotoxic activities against a variety of cancer cells, including P-388 murine 
leukemia, A-549 human lung carcinoma, HT-29 human colon carcinoma and MEL-28 human 
melanoma.17 
Noteworthy, too, is the fact that many clerodanes exhibit other interesting biological 
properties, providing opportunities to better understand biological processes in more general 
terms. For instance, teucvin (6)18, isolated from the Mallotus (Euphorbiaceae) and Teucrium 
(Labiatae) genera, has been shown to be amoebicidal and can act as a root development 
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inhibitor,19 while agelasine A (22) and B (23) have been reported as Na,K-ATPase inhibitors20 
which have trans- and cis-clerodane moieties respectively. 
 
Indeed, to have such a range of activities within a given class is impressive, and argues 
strongly that a comprehensive codification of structure-activity relationships could be of broad 
value in the design of even more potent and selective materials. Therefore, the clerodane family 
has attracted substantial attention from synthetic chemists. 
 
1.4    Selected Total Syntheses of Clerodane Terpenoids 
Prior to 1980s, synthetic efforts towards the clerodane class were relatively limited, in 
spite of a rapid increase in numbers of isolated natural products. By contrast, a large body of 
work has appeared during the last thirty-five years, driven largely, we believe, by their complex 
structures and promising biological activities as noted above.  
In 2000, Tokoroyama published a thorough and detailed review5 summarizing the 
syntheses of clerodane and related terpenoids. So far, the key question addressed in most 
syntheses of clerodanes is how to construct the decalin framework with the contiguous 
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stereogenic centers. Herein, only a select collection of total syntheses will be presented, focusing 
our discussion on classic disconnection strategies and recent developments to form the 
characteristic decalin ring of the class. Although a few other important synthetic studies in the 
clerodane realm have been conducted,21 their discussion will be deferred to later chapters in the 
cases where they are relevant to key design considerations of our own approach.  
 
1.4.1   Total Synthesis of (–)-Ilimaquinone (24)22 
The Wieland–Miescher type of diketone (25)23 is a versatile synthon which has been 
employed predominantly in the total synthesis of terpenoids and steroids. Either optically pure 
enantiomer is available via amino acid-assisted asymmetric cyclization and subsequent product 
recrystallization.24 Following the first total synthesis of clerodane diterpenoid by Kakisawa in 
1979,25 Wieland–Miescher diketone of type 25 has been widely utilized as starting material for 
the synthesis of this family. As an example, the Samadi synthesis of (–)-ilimaquinone (24), 
achieved in 1998, will be discussed below.22 
 
The marine natural product ilimaquinone (24)26 was demonstrated to inhibit the toxicity 
of ricin and diphteria toxin,27 to reversibly disrupt the Golgi complex,28 and to provoke the loss 
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of the gap junction plaques and inhibition of intercellular communication in BICR-MIRk and 
NRK cells.29 Thus, ilimaquinone appears as a valuable tool for the investigation of some 
important biological processes. In this vein, the Samadi group aimed to install the quinine moiety 
(26) by alkylation of enone (27), a material that, in turn, could be traced back to Wieland–
Miescher diketone (25). 
 
In the event, Wieland–Miescher diketone (25, Scheme 3) was selectively protected as its 
monoketal derivative, followed by Birch reduction of the double bond to give the saturated 
ketone 28 as a single isomer. Ketone 28, in turn, was then converted into the corresponding 
enone (27) via Saegusa oxidation. Next, coupling of 27 through its lithium dienolate in the 
presence of benzyl bromide 26 cleanly furnished addition product 29 as a single isomer. The 
product of catalytic hydrogenation of 29 was subsequently submitted to Wittig olefination to 
give exo olefin 30. Finally, hydrogenation of olefin 30 over Pd/C in Et3N afforded compound 31 
11 
 
with 9:1 d.r., which afforded 10 step synthesis of ilimaquinone (24) from Wieland–Miescher 
diketone (25). 
 
1.4.2   Total Syntheses of (±)-Mamanuthaquinone (32)30 and (±)-Teucvin (6)31 
In spite of limited application of intramolecular Diels–Alder reactions with the class, two 
types of intermolecular Diels–Alder strategies have been widely employed in the stereoselective 
construction of clerodane and related skeletons (Scheme 4). 
 
For the first approach, termed as type A, an intermolecular Diels–Alder reaction using 1-
vinylcyclohexene derivatives of type 34 as the diene component would simultaneous establish 
three stereogenic centers at C-8, C-9, and C-10. While the task for the introduction of an angular 
substituent at C-5 remains to be fulfilled for the synthesis of clerodanes, the present method 




In the course of total synthesis of (±)-mamanuthaquinone (32),30 the Danishefsky group 
investigated the stereoselectivity of a Diels–Alder reaction between vinylcyclohexene 38 and 
enone 39. When mediated by EtAlCl2, this cycloaddition afforded a single diastereomer in the 
form of 40. In this case, the endo mode of the reaction is highly disfavored due to repulsion of 
the sterically demanding aroyl group with the dimethyl quaternary carbon on the diene (Scheme 
5). With cycloadduct 40 in hand, a reduction/acylation/Birch reduction sequence gave phenol 41, 
which in turn provided mamanuthaquinone (32) via several routine chemical transformations. 
By contrast, the type B method, which utilizes cyclohexenone or benzoquinone 
derivatives in the form of 37 (Scheme 4) as the dienophile component, generally allows the 




            In the total synthesis of (±)-teucvin (6),31 the Liu group showcased a ZnCl2–catalyzed 
Diels–Alder reaction of dienophile 42 and diene 43. This reaction occurred in a completely facial 
and stereoselective (endo) manner, as a result of concomitant intramolecular hemiacetal 
formation. Subsequent acylation of cycloadduct 44, followed by conjugate addition, afforded 
compound 45 which was, in turn, deformylated under the condition of NaOH in EtOH. Then, 
catalytic hydrogenation of 46 followed by Jones oxidation provided acid 47. Next, the γ-lactone 
ring was introduced by a sequence of enol lactone ring formation and double bond isomerization. 
Under thermodynamic–controlled conditions (p-TsOH in refluxing benzene), the more stable 
epimer 48 was obtained as the sole product. Finally, continuation of the synthesis from 48 





1.4.3   Total Synthesis of (±)-Linaridial (50)32 
In 1987, the Tokoroyama group published the first total synthesis of linaridial (50)32 
through a route which centered upon the use of the Hosomi–Sakurai reaction to construct the 
decalin core with diastereocontrol at three contiguous carbon (Scheme 7). 
 
In the key event, the cyclization of allylsilane substrate 52 in the presence of TiCl4 and 
chloromethyl methyl sulfide (ClCH2SMe) was found to afford a single diastereomer of product 
in the form of 53 under perfect dual stereo-regulation, an outcome which can be explained in 
terms of orientation and folding-strain stereocontrols (Scheme 8). From an orientation 
perspective on stereocontrol, antiperiplanar transition state (TS) 54 should be favored over 
synclinal TS 55 if a chair-like conformation is assumed to be preferred. The folding-strain 
stereocontrol is concerned with diastereofacial selection with regard to the C-8 position. Of the 
two possible diastereomeric foldings (54 and 56), 54, with the pseudo-equatorial methyl group, 




Next, with decalin 51 in hand, reductive removal of the methylthio group in 51, followed 
by methylenation using the Nozaki procedure, worked excellently to yield diene 53. From here, 
the total synthesis of linaridial 50 was achieved in six additional steps. 
 
1.4.4   Total Synthesis of (±)-Maingayic acid (57)33 
 
Robinson-type annulation reactions have also been widely used to assemble the decalin 
skeleton of the clereodane terpenoids. For instance, Tokoroyama and co-workers’ total synthesis 
16 
 
of (±)-maingayic acid (57, Scheme 9) featured a modified Robinson annulation protocol of 
compound 59 which could be readily obtained from commercially available starting materials.33 
 
In the forward sense, stereoselective conjugate addition of vinyl cuprate to enone 60 and 
subsequent modified Robinson annulation afforded compound 58. The stereogenic center at the 
ring junction (C-10) is favorably introduced under thermodynamic control. Next, hydrocyanation 
of 58 yielded trans-addtion product 62, from which a total synthesis of maingayic acid 57 was 
accomplished.  
 
1.4.5   Total Synthesis of (–)-Solidagolactone (63)34 
In a recent example of a total synthesis of the clerodane natural products, the Overman 
group aimed to employ a radical 1,6-addition to install the side chain at the C-9 position. As 
additional key disconnections, they planned to complete the decalin framework of 64 through an 




In the actual synthesis, beginning with the readily available alkyne 65 and enone 66, 
Nickel-catalyzed hydroalumination, followed by catalytic enantioselective conjugate addition of 
the resulting internal vinylaluminum intermediate using Hoveyda’s silver-NHC complex, gave 
67 with high enantio-enrichment. Chlorohexanone 67 was then cyclized into decalone 68. This 
material was then methylated and converted into nitrile 69 upon base-promoted reaction with p-
toluenesulfonylmethyl isocyanide (TosMIC). From 69, they were able to reach (N-
acyloxy)phthalimide 64, which when exposed to visible light in the presence of Ru(bpy)3(BF4)2, 
the Hantzsch ester, and vinylbutenolide, afforded the desired coupling product in high yield as a 
single diastereomer. This critical operation which had stereoselection at C-9 is reasoned by 
coupling of the tertiary radical with radical acceptor from the less-hindered equatorial face (71). 
From here, straightforward double bond isomerization of the resulting product using RuCl3 then 





1.5    Conclusions 
Chemists have rallied over the last several decades to produce many appealing synthetic 
solutions to the clerodane family of natural products. The interest in these materials has strongly 
been driven by the rich diversity of structure and biological activities that this family holds, as 
well as the opportunity for synthetic innovation, principally focused on the stereoselective 
construction of the decalin framework. As will be seen in the following chapters, it was these 
attractive features that drew our attention to the clerodane terpenoids as compelling targets for 
total synthesis, and afforded the opportunity to develop a number of strategies and tactics distinct 
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DESIGN OF A GENERAL SYNTHETIC APPROACH TOWARDS  











2.1   Introduction 
As can be gleaned from the examples laid out in Chapter 1, the clerodane class of 
terpenoids presents an array of intriguing structures for which many creative synthetic solutions 
have been reported over the last four decades.1 However, the majority of synthetic efforts to date 
only target a single molecule or a series of closely related natural products. Furthermore, the 
scarcity of total syntheses of multiply oxygenated clerodanes provides great potential to develop 
a general synthetic approach, which could easily divert to structurally distinct clerodanes with a 
broad range of oxidation levels. As such, coupled with interests in the unexplored biological 
activities, we decided to initiate a synthetic program seeking to deliver clerodane natural 
products with a wide scope of carbon frameworks and functionalities through a unified design 
and the use of a key synthetic intermediate. 
 
This chapter will begin with our design of a two-phase approach towards the clerodane 
family, followed by an introduction of scaparvin A (1)2 as an excellent example of a target with 
complex architecture and multiple oxygenated functional groups worthy of synthetic and 
biological study. Finally, a detailed retrosynthetic analysis of scaparvin A (1) will be described 
based on our global strategy for accessing the family.  
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2.2   Our Design of Synthetic Approach towards Clerodane Terpenoids   
Given the biosynthesis noted in Section 1.2, natural production of clerodane terpenoids 
involves both a cyclase phase and a subsequent oxidase phase employing bicyclic compound 6 
(or ent-6) as a common precursor to deliver cis-clerodanes with a high degree of structural 
diversity (Scheme 1). Considering the large number of structurally distinct molecules 
synthesized in Nature, this divergent oxidase phase process is extremely efficient if Nature’s 
synthesis at this stage is meant to be controlled. Unfortunately, in any event, such chemo- and 
stereoselective oxidations are generally beyond the current capabilities of chemical synthesis. As 
such, a step-by-step emulation of these oxidation sequences is likely difficult, if not impossible, 
to execute in a laboratory setting. 
 
However, we envision that a similar two-phase chemical synthetic approach could be 
achieved if a properly functionalized “common intermediate” in the form of 7 could be 
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synthesized (Scheme 1). The first phase focuses on the construction of the carbon skeleton, a 
problem which is mainly solved as it has been investigated in previous synthetic studies from 
other teams. The second phase, the more challenging part of the design, should involve one or 
several key site-selective chemical transformations that could utilize tools largely fueled by an 
immense resurgence of C–H functionalization in the past two decades, as well as new reactions 
and reagents to accomplish previously unachievable oxidation events.3 The groups labeled as R 




After careful examination of the general oxidative patterns of cis-clerodanes, we believe 
that an ideal candidate of the “common intermediate” in this approach could be compound 8 (or 
ent-8) with four contiguous stereocenters to dedicate following diastereoselectivity, and more 
importantly, proper functional groups such as a C3–C4 double bond and oxygen-based 
functional groups at C-6, C-11, and C-19 to facilitate further site-selective modifications. As 
shown in Scheme 2, a series of cis-clerodanes, shown here as scaparvin (1)2, salvifarin (2)4, 
fibleucin (3)5, teucvin (4)6, popolohuanone E (9)7 and cordifolide A (10)8, could likely be 
derived from “common intermediate” 8 (or ent-8) if suitable site-selective synthetic 
transformations are developed and applied to solve the highlighted oxidation level discrepancies 
between these natural products and the “common intermediate” 8 (or ent-8). 
Globally, this proposed two-phase approach can also serve as a platform to test the 
reactivity and selectivity of the existing C–H functionalization protocols in complex structural 
settings, and in turn afford insights to further optimize, revamp, and develop new methods. 
Additionally, from the viewpoint of chemical biology, this approach could not only allow access 
to naturally-occurring compounds, but also unnatural analogs to investigate structure-activity 
relationships in a systematic manner. Thus, we decided to investigate the feasibility of this 
approach, starting by an attempt to achieve a total synthesis of scaparvin A (1).  
 
2.3   Introduction of Scaparvin A (1) 
Scaparvin A (1, Figure 2) was isolated in 2010 by Lou and co-workers along with four 
related cis-clerodanes, scaparvins B-E (11-14), from the epilithic liverwort Scapania parva Steph. 
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Its unique structure was assigned through a combination of advanced 1D and 2D NMR 
techniques, buttressed by CD and HRMS data. 
 
Structurally, scaparvin A (1) features a novel cage structure bridged with a distinct C-
6/C-11 bond and intramolecular ketal at C-12, with seven contiguous stereocenters along the ring 
system (5 of which are fully substituted and 2 of which are quarternary). It is worth noting that 
there are four oxygenated carbons (C-6, C-10, C-12, and C-19) located within a very congested 
space, which makes the structure quite synthetically challenging in terms of potential functional 
group manipulation. Hence, we believe scaparvin A (1) could serve as an exceptionally suitable 
target to justify our global synthetic logic, with the other scaparvins as possible targets of 
opportunity as well, differing largely with the absence of the C6–C11 bond that completes the 
cage of 1.  
 
2.4   Retrosynthetic Analysis of Scaparvin A (1) from Common Intermediate (8) 
Based on our global strategy as described in broad terms in Section 2.2, scaparvin A (1) 
could be derived from a diol precursor such as 15, which in turn could arise from C6–C11 bridge 
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formation of ketoaldehyde 16. This key chemical transformation was envisioned to be 
accomplished through either an aldol reaction or a Pinacol coupling/oxidation protocol. 
Comparing 16 with “common intermediate” 8, the tertiary C–H bond at C-10 required to be 
oxidized selectively over the sterically more accessible C–H bond at C-8, and allylic C–H bonds 
at C-2 and C-18.  It was hoped that this key event could be accomplished with 17. Finally, the 
preoxidized compound 17 could be traced back to “common intermediate” 8 through several 
straightforward functional group manipulations.  
 
 
2.5   Conclusion 
As detailed in the above sections, we have designed a two-phase approach towards cis-
clerodane terpenoids, with scaparvin A (1) serving as an example to highlight the key synthetic 
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challenges. As will be described in the ensuing chapters, a number of strategies and tactics have 
been developed to address these problems. We will focus our discussion in Chapter 3 on the 
efficient construction of “common intermediate” 8, while two modes of directed C–H oxidation 
at C-10 will be covered in Chapter 4. Finally, efforts of late-stage modification towards 
scaparvin A (1) and related compounds will be summarized in Chapter 5, culminating in a near 
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CONCISE SYNTHESIS OF A COMMON INTERMEDIATE  











3.1   Introduction 
Given the global synthetic logic described in Chapter 2, compound 1 (Scheme 1) could 
serve as a common precursor for the synthesis of the cis-clerodane terpenoids, represented here 
by scaparvin A (2). Thus, our first task was to develop an efficient method to construct the 
decalin system stereoselectively, keeping in mind that gram-scale quantities of that common 
intermediate 1 would be ideal to truly fuel the next stage of studies towards 2 as well as other 
targets.  
 
This chapter will detail the evolution of our synthetic approach to 1, beginning with a 
failed pyrone Diels–Alder strategy that could not deliver the core. That discussion will be 
followed by our attempts to assemble its characteristic framework empowered by an 
intramolecular Conia-ene reaction. Finally, approaches to obtain optically pure 1 will be 
illustrated as well.  
 
3.2   Pyrone Diels–Alder Approach to Common Intermediate 
The Diels–Alder reaction is particularly useful in synthetic organic chemistry as a reliable 
method for forming six-membered systems with good control over both regio- and 
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stereochemical properties in how its two partners are merged.1 Among diene components, the 2-
pyrone hetero-cycle has been widely exploited to assemble the [2.2.2]-bicyclic lactone motif 
characteristic in general terms of the desired decalin framework needed for synthesis.2 Thus, 
mindful of our aforementioned goal to deliver 1 in a concise, efficient, and scalable fashion, we 
were drawn to the notion that its stereochemically rich decalin framework could arise from a 
pyrone Diels–Alder reaction shown in Scheme 2 using an ,-unsaturated cyclohexanone or 
quinone as a coupling partner. 
 
More specifically, common intermediate 1 could retrosynthetically be derived from a 
bridged lactone precursor 3, which in turn could be traced back to pyrone 5 and dienopile (6, 7, 
or 8) through an endo selective [4+2]-cycloaddtion, assuming that the transformation could be 
achieved at a temperature low enough such that the resultant product would not decompose 
through a retro [4+2]-cycloadditon expelling CO2. Finally, both Diels–Alder components would 
be readily obtained from commercially available starting materials. 
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In the forward sense, our studies began with the preparation of pyrone 5 (Scheme 3). As 
shown, a rhodium-catalyzed cyclopropenation of 2-butyne (9) with ethyl diazoacetate (10) gave 
cycloadduct 11 in 83% yield which, upon treatment of [Rh(CO)2Cl]2 under a CO atmosphere, 
afforded pyrone 5 through a sequence that likely involves oxidative addition, carbonyl insertion, 
1,3-migration, and reductive elimination.3  It is worth noting that these two catalytic reactions 
could be carried out with relatively low catalyst loadings and that we could readily obtain diene 5 
on multigram scale. 
 
As for the dienophile partner, we decided to examine compounds 6, 7, and 8 for the 
following reasons. First, the electron-withdrawing groups in the dienophiles could dedicate to 
regioselectivity of the normal demand Diels–Alder reaction, given that with pyrone dienes there 
is little opportunity to tune regioselectivity or reactivity through other standard techniques such 
as Lewis acid catalysts since complexation can occur with both components. Second, particularly 
for 8, π-π stacking between the planar quinone motif with pyrone 5 might accelerate the reaction, 




The syntheses of the dienophiles proved to be very straightforward (Scheme 4). A 
Baylis–Hillman reaction of commercially available cyclohexenone (15) afforded dienophile 6,4 
while 7 was obtained from ketoester 16 via α-selenenylation followed by oxidative selenoxide 
elimination.5 A silver(I)-mediated oxidation of hydroquinone 17 delivered quinone 8 smoothly in 
76% yield.  
With both the diene and dienophiles in hand, we then turned our attention to investigating 
the proposed Diels–Alder reaction, starting with cycloadditions promoted by thermal activation. 
Unfortunately, these attempts only gave uncharacterizable mixtures of by-products at high 
temperatures (100–150 °C), while no conversion was observed at lower temperatures (50–80 °C).  
Scheme 5 illustrates our rationale for this unsuccessful Diels–Alder reaction. The 
sterically demanding, fully substituted carbons at C-5, C-6, and C-9, along with the partially 
aromatic nature of pyrones (caluculated to be ca. 30% as aromatic as benzene),6 likely require 
significant thermal activation to participate in the [4+2] cycloaddition. However, the subsequent 
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entropy-driven loss of CO2 will be dramatically accelerated at such high temperatures, which 
could quickly consume transient oxabicyclooctene 3. In order to overcome the low reactivity and 
suppress the loss of CO2, reactions performed under high pressure (~300 psi) at lower 
temperatures were also tested, but again showed disappointing results. 
 
In light of this outcome, we sought to improve the reactivity of our dienophile by using 
Lewis acids, aiming to lower the reaction temperature. However, despite much experimentation 
using various Lewis acids (Scheme 6), the desired Diels–Alder products were not observed. 
Indeed, this outcome affording complex mixtures of by-products is not that surprising, especially 
when strong Lewis acids (e.g. TiCl4, SnCl4, BF3•OEt2) were used. For instance, Lewis acids 
might not only be confused in terms of promoting the [4+2] cycloaddition based on which 
partner they complexed with, but if the reaction had occurred, they might also assist in ring 
opening of the partially-strained [2.2.2]-bicyclic lactone. Scheme 6 showcases a possible reaction 




Thus, we drew the conclusion that the proposed pyrone Diels–Alder reaction shown 
above is likely challenging to reduce to practice, mainly due to sterically demanding nature of 
the reaction and the labile [2.2.2] bicyclic motif. At this juncture, we elected to redesign our 
retrosynthetic analysis of common intermediate 1, using alternative strategic disconnections to 
forge its key bonds and stereocenters.   
 
3.3   Conia-Ene Approach to Common Intermediate 
The key lesson learned from the failed pyrone Diels–Alder strategy is that it might be 
difficult to intermolecularly assemble the requisite highly substituted decalin system in a single 
step. Thus, we switched to an approach that would construct it in a stepwise manner, but still 
hopefully in a modicum of operations as predicted by the Conia-ene approach highlighted in 
Scheme 7.  Here, initial disconnection of the C4–C5 bond in the common intermediate shown 
here in protected form as 20 led back to alkyne 21, a material bearing all the carbon atoms of the 
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final decalin system. This material (21), in turn, could potentially arise from enone 22 through a 
Cu-mediated conjugate addition, while this resultant compound could be further traced back to 
ketoaldehyde 23. Finally, compound 23 was seen as the product of Diels–Alder reaction between 
tiglic aldehyde 24 and Rawal’s diene 257. And, if that Diels–Alder reaction could be achieved 
asymmetrically, then an enantiospecific synthesis could result if the initial chiral centers present 
in 23 assisted in directing the formation of all the remaining chirality centers in a stereoselective 
manner. 
 
With this plan in mind, we set about testing the initial Rawal-type Diels–Alder reaction.  
In the event, mixing tiglic aldehyde 24 with a slight excess of Rawal’s diene 25 and heating in 
THF at 50 °C for 12 h, followed by treatment with ethylene glycol under acidic conditions, led 
exclusively to the thermodynamically stable acetal 22. Next, the resulting enolate from the Cu-
mediated conjugate addition was quenched by Mander’s reagent8 (noting that other reagents such 
as ClCO2Me mainly afforded O-acylated products) to afford alkyne 26 in 55% yield and with 5:1 
dr. At this stage, it proved challenging to assign the configuration of the newly formed C-10 
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stereocenter because 26 exists as a tautomeric mixture of enol and ketone forms, complicating 
NMR analysis. As such, we elected to carry the major diastereomer forward to the Conia-ene 
reaction, hoping we could determine the stereochemistry from the decalin system formed. 
 
In that key step, despite extensive failures to effect the Conia-ene reaction under gold 
catalysis,9 we were pleased to find that In(OTf)3 could serve as an effective Lewis acid to 
promote the desired transformation. Indeed, upon aqueous work-up, ketoaldehyde 27 was the 
only isomer observed, the stereochemistry of which was assigned through a combination of 
NOSEY and other 2D NMR to that as drawn.  
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The generation of the undesired stereochemistry within product 27 versus target 20 
suggests that the conjugate addition of 22 occurred from the β-face. In order to understand and 
potentially invert the facial selectivity, conformational analysis of enone 22 (as shown in Scheme 
9) indicates that 22 should exist predominantly as conformer 31 with methyl and acetal group at 
pseudo-equatorial positions. If so, then axial attack of the organocopper reagent will result in the 
undesired stereomer as observed.  
 
In order to overcome this innate facial selectivity, one reasonable solution is to introduce 
a bulky group that could block the preferred face of attack within the cyclohexenone system, 
forcing the conjugate addition proceed from the alternate side. For example, in the Ley total 
synthesis of insect antifeedant ajugarin I, 1,3-dithiolane moiety was reported to be capable of 
controlling the facial selectivity during a Cu-mediated conjugate addition.10 In this case, the 
complexation between dithiolane moiety and copper (I) species acts as a “bulky” group to 
prevent nucleophilic attack from the β-face irrespective of which chair conformer is attacked by 




To probe this tactic, we simply needed to switch the protecting group of the C-11 
aldehyde to dithiolane moiety. Again, starting from Diels–Alder product 35 (Scheme 11), 
treatment with a stoichiometric amount of 1,2-ethanedithiol and silica gel that had been pre-
treated with thionyl chloride was able to selectively protect the C-11 aldehyde and afford 32 in 
73% yield. It is worth mentioning that other conditions to effect this protection using Lewis acids 
or protic acids, in contrast to thioacetalization, usually gave a mixture of compounds (32, 38, 39, 




Subjecting 32 to the same conjugate addition conditions pleasingly delivered the desired 
C-10 epimer in the form 36, which was then cyclized to cis-decalin bicycle 37 under the Conia-
ene reaction conditions. Here, in this key event, InCl3 was found to be the optimal In(III)-based 
Lewis acid to effectively promote the double bond migration of the resulting Conia-ene product, 
affording endo-olefin 37 in 77% yield. Notably, over 10 grams of common intermediate 37 have 
been prepared through this concise route (4 steps from Rawal’s diene 25), thereby providing 





3.4   Enantioselective Synthesis of Common intermediate 
Having successfully developed a reliable racemic route towards 37 as described in the 
previous section, we next set our sights on an enantioselective preparation to this common 
intermediate. Based on the synthetic route noted above, the initial chiral centers (C-8, and C-9) 
were generated during the Diels–Alder reaction; as such, a straightforward idea is to incorporate 
enantiomeric control in the Diels–Alder reaction. 
 
In 2000, the Rawal group described a highly enantioselective Diels–Alder reaction of 
their diene as catalyzed by Cr(III) salen complex (Scheme 12).11 Comparing the structures of 
acrolein substrates (40) with tiglic aldehyde 24, we expected that 24 might have lower reactivity 
due to the steric hindrance at C-8 position, and consequently might require higher temperature or 
44 
 
stronger Lewis acids that might be less effective in terms of final enantiocontrol. To our delight, 
a small screen of the reaction conditions (temperature, solvent and counterion of the catalyst) 
revealed that using the catalyst possessing a SbF6
- counterion at slightly higher concentration 
(2.0 M) in CH2Cl2 gave optimal yield and enantiomeric excess (86%, 94% ee) and reasonable 
reaction time (2 d). 
 
 Encouraged by this crucial result, we next set to convert 44 into 32, the intermediate 
previously formed in the racemic route. After numerous unsuccessful attempts of thioacetal 
formation promoted by Lewis acids or protic acids (because of vinyl ether cleavage and further 
reactions), the required dithiolane moiety was accomplished by employment of a neutral reagent 
Me2AlSCH2CH2SAlMe2 (3 equiv, prepared in situ from ethanedithiol and Me3Al, developed by 
the Corey group).12 Subsequent reduction of carbamate 45 provided optically pure enone 32 
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upon acidic work-up. After recrystallizing this material using Et2O/hexanes as solvent, a step 
which served to enhance the level of enantioselectivity to >98%, we were then able to advance it 
to common intermediate 37 using the chemistry described previously for the racemic route. 
 
3.5   Conclusion 
As detailed in this chapter, we have developed a concise stereoselective synthesis of the 
common intermediate 37 which proceeded in 4 step (5 steps for enantioselective route) from 
Rawal’s diene (25 or 41), highlighting the power and utility of Rawal’s Diels–Alder reaction. 
Additional key elements were a facially selective conjugate addition as controlled by dithiolane 
moiety and an InCl3-promoted Conia-ene reaction to rapidly assemble the remaining compounets 
of the decalin core. 
 
With sufficient quantities of common intermediate 37 prepared, we were set to proceed to 
the next phase of our synthetic plan, namely modification of 37 into various scaparvin terpenoids, 
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3.7   Experimental Section 
General Methods: All reactions were carried out under an argon atmosphere with dry 
solvents under anhydrous conditions, unless otherwise stated. Dry methylene chloride (CH2Cl2), 
diethyl ether (Et2O), tetrahydrofuran (THF), benzene and toluene were obtained by passing 
commercially available pre-dried, oxygen-free formulations through activated alumina columns; 
triethylamine (Et3N) was distilled from KOH; dichloroethane (DCE), acetonitrile (CH3CN) and 
methanol (MeOH) were purchased in anhydrous form from Sigma-Aldrich and used as received. 
Yields refer to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated. Reagents were purchased at the highest commercial quality 
and used without further purification, unless otherwise stated. Reactions were magnetically 
stirred and monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. Merck 
silica gel plates (60F-254) using UV light and an aqueous solution of cerium ammonium sulfate 
and ammonium molybdate and heat as visualizing agents. Preparative TLC was carried out on 
0.50 mm E. Merck silica gel plates (60F-254). SiliCycle silica ge (60 A, academic grade, particle 
size 40-63 µm) was used for flash column chromatography. NMR spectra were recorded on 
Bruker DRX-300, DRX-400, DRX-500 and DRX-700 instruments and calibrated using residual 
undeuterated solvent as an internal reference. The following abbreviations are used to explain 
multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = 
apparent. IR spectra were recorded on a Perkin-Elmer Spectrum Two FT-IR spectrometer. High 
resolution mass spectra (HRMS) were recorded in the Columbia University Mass Spectral Core 
facility on a JOEL HX110 mass spectrometer using FAB (Fast Atom Bombardment). 
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Enone 32. To a solution of (E)-1-dimethylamino-3-tert-butyldimethylsiloxy-1,3-
butadiene (25, 58.7 g, 259 mmol, 1.2 equiv) in THF (200 mL) at 23 °C was added tiglic aldehyde 
(24, 20.8 mL, 216 mmol, 1.0 equiv). The stirred reaction was then heated to 50 °C for 16 h. After 
cooling down to 23 °C, the reaction was quenched by 2 M HCl solution (200 mL) and further 
stirred for 5 h at this temperature. The reaction contents were then transferred to a separatory 
funnel, diluting with EtOAc (300 mL) and saturated aqueous NaHCO3 (300 mL). The organic 
layer was separated and the aqueous layer was extracted with EtOAc (3  100 mL). The organic 
layers were combined, dried with MgSO4, filtered and concentrated. The resulting crude product 
was purified by flash column chromatography (silica gel, hexanes/EtOAc, 10:1 to 4:1) to give 
cycloadduct 35 (24.2 g, 74% yield) as a yellow oil.  
A portion of this product (35, 17.0 g, 112 mmol, 1.0 equiv) was dissolved in benzene (1.5 
L) and cooled to 0 °C. SiO2-SOCl2 (40 g) was added in one portion, followed by addition of 1,2-
ethanedithiol (9.4 mL, 112 mmol, 1.0 equiv). After 10 min, the ice-water bath was removed and 
the reaction mixture was allowed to warm to 23 °C for 16 h. Upon completion, the reaction 
contents were filtered through Celite (rinsing with EtOAc) and transferred to a separatory funnel. 
After washing with saturated aqueous NaHCO3 (400 mL), the organic layer was separated and 
the aqueous layer was extracted with EtOAc (3  200 mL). The organic layers were combined, 
dried with MgSO4, filtered and concentrated. The resulting crude product was purified by flash 
column chromatography (silica gel, hexanes/EtOAc, 20:1 to 8:1) to give enone 32 (17.0 g, 73% 
yield) as a yellow oil. 32: Rf = 0.53 (silica gel, hexanes/EtOAc, 4:1); 
1H NMR (400 MHz, CDCl3) 
δ 7.12 (d, J = 10.3 Hz, 1 H), 6.01 (d, J = 10.3 Hz, 1 H), 4.89 (s, 1 H), 3.33–3.12 (m, 4 H), 2.45–
2.20 (m, 3 H), 1.15 (s, 3 H), 1.00 (d, J = 6.5 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 199.0, 
155.3, 129.0, 61.6, 44.2, 42.2, 39.0, 38.8, 37.4, 18.9, 15.3. 
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Alkyne 36. Magnesium turnings (10.2 g, 425 mmol, 5 equiv) was weighed directly into a 
flame-dried flask, whereafter a solution of 1-bromo-5-(trimethylsilyl)-4-pentyne (46.5 g, 212 
mmol, 2.5 equiv) in Et2O (500 mL) was slowly added at 23 °C over 1 h. After vigorous stirring 
for an additional 4 h, the resultant solution of Grignard reagent was slowly transferred into a 
vigorously-stirred suspension of CuBr-SMe2 (21.8 g, 106 mmol, 1.2 equiv) in Et2O (200 mL) at 
–78 °C through a cannula. The reaction contents were slowly warmed to –60 °C over 1 h, and 
then cooled to –78 °C. A solution of enone 32 (17.2 g, 82.7 mmol, 1.0 equiv) in Et2O (200 mL) 
was added dropwise, and the reaction contents were slowly warmed to 23 °C over 10 h. After 
cooling to –78 °C again, HMPA (150 mL) and Mander’s reagent (20.2 mL, 254 mmol, 3 equiv) 
were added dropwise, and the reaction contents were slowly warmed to 23 °C over 16 h. Upon 
completion, the reaction mixture was diluted with MeOH (200 mL) and filtered through a pad of 
Celite (rinsing with Et2O). To the resulting filtrate was added a solution of TBAF in THF (1.0 M, 
300 mL). The resulting solution was stirred at 23 °C for 10 h before being quenched with a 
mixture of NH4OH (50 mL) and saturated aqueous NH4Cl (300 mL). The reaction contents were 
then transferred to a separatory funnel, diluting with hexanes (500 mL) and water (500 mL). The 
organic layer was separated and the aqueous layer was extracted with EtOAc (3  400 mL). The 
organic layers were combined, dried with MgSO4, filtered and concentrated. The resulting crude 
product was purified by flash column chromatography (silica gel, hexanes/EtOAc, 50:1 to 15:1) 
to give alkyne 36 (17.8 g, 61% yield) as a yellow oil. 36: Rf = 0.58 (silica gel, hexanes/EtOAc, 
10:1); 1H NMR (400 MHz, CDCl3) δ 12.34 (s, 1 H), 4.84 (s, 1 H), 3.77 (s, 3 H), 3.25–3.07 (m, 4 
H), 2.62 (dd, J = 7.3, 18.8 Hz, 1 H), 2.48 (m, 1 H), 2.14 (dt, J = 2.6, 7.0 Hz, 2 H), 2.08–1.85 (m, 
4 H), 1.65–1.53 (m, 2 H), 1.30 (m, 1 H), 1.22 (s, 3 H), 1.10 (d, J = 7.3 Hz, 3 H); 13C NMR (100 
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MHz, CDCl3) δ 173.1, 170.6, 101.0, 84.5, 68.2, 64.2, 51.5, 44.5, 41.7, 39.2, 38.4, 35.2, 34.3, 
32.8, 29.4, 19.6, 18.6, 15.6.  
Common Intermediate 37. To a suspension of InCl3 (7.2 g, 32.5 mmol, 1.0 equiv) in 
DCE (300 mL) at 23 °C was added a solution of alkyne 36 (11.5 g, 32.5 mmol, 1.0 equiv) in 
DCE (200 mL). The stirred reaction was then heated to 80 °C for 16 h. After cooling down to 
room temperature, the reaction was quenched by saturated aqueous NaHCO3 (300 mL) and 
further stirred for 30 min at this temperature. The reaction contents were then filtrated through a 
pad of Celite (rinsing with CH2Cl2), and transferred to a separatory funnel. The organic layer was 
separated and the aqueous layer was extracted with CH2Cl2 (3  100 mL). The organic layers 
were combined, dried with MgSO4, filtered and concentrated. The resulting crude product was 
purified by flash column chromatography (silica gel, hexanes/EtOAc, 20:1 to 5:1) to give 
common intermediate 37 (8.86 g, 77% yield) as a yellow oil. 37: Rf = 0.41 (silica gel, 
hexanes/EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) δ 5.85 (br, 1 H), 4.76 (s, 1 H), 3.78 (s, 3 H), 
3.34–3.12 (m, 4 H), 3.08 (dd, J = 3.0, 13.3 Hz, 1 H), 2.84 (dd, J = 6.2, 17.8 Hz, 1 H), 2.36 (m, 1 
H), 2.17–1.97 (m, 4 H), 1.58 (m, 2 H), 1.11 (m, 1 H), 0.96 (d, J = 6.6 Hz, 3 H), 0.95 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 207.9, 173.3, 129.4, 128.5, 65.1, 65.1, 52.4, 44.9, 44.3, 43.7, 38.5, 




























































EXPLORATION OF SITE-SELECTIVE C–H OXIDATION  











4.1   Introduction 
With the gram scale synthesis of common intermediate 3 achieved, we then moved to the 
second phase of our studies, namely modification of the decalin framework to full scaparvin 
terpenoids (Scheme 1). Comparing the structure of common intermediate 3 with scaparvin A (4), 
in particular, the most challenging element of the transformations envisioned involves an 
oxidation at the C-10 position through some means of C–H oxidation. This chapter details the 
evolution of our approach for that site-selective oxidation, beginning with efforts to utilize a 
Hofmann–Loffler–Freytag strategy. That discussion will be followed by our attempts to facilitate 
a directed C–H oxidation using materials with a locked molecular conformation. Finally, some 
additional and critical optimizations of the overall synthetic route will be discussed as well.  
 
 
4.2   C-10 Oxidation via Hofmann–Loffler–Freytag Strategy 
Given the retrosynthetic analysis of scaparvin A (4) presented in Chapter 2, we hoped 
that key intermediate 5 could serve to deliver several scaparvin terpenoids, including scaparvin A 
(4, Scheme 2). In order to obtain 5 from common intermediate 3, the C-10 position must be 
oxidized selectively. However, achieving this chemical transformation was expected to be 
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difficult given the presence of the sterically more accessible tertiary C–H bond at C-8, as well as 
the more activated allylic C–H bonds at C-2 and C-18 within the molecule.  
 
Because the C–H bond at C-10 is neither sterically favored nor electronically favored, we 
envisioned that C–H oxidation chemistry effected in an intermolecular fashion would be unlikely 
to achieve the desired oxidation selectively over other potential reactive sites. By contrast, if a 
proper functional group within the structure could be exploited as a directing group, then the 
innate requirements of the reaction’s cyclic transition state might provide the desired site-
selectivity. For instance, when radical-generating functionality is installed at C-19 position, the 
resulting radical (7, Scheme 2) is expected to intramolecularly abstract the hydrogen at C-10 
position through a cyclic transition state. Subsequent radical quenching of the resulting tertiary 
radical 6 could result in a formal C–H oxidation. 
A thorough review of the literature afforded a promising precedent in the work of Baran1 
who reported a radical-mediated C–H oxidation using a trifluoroethyl carbamate moiety as a 
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directing group (Scheme 3). This Hofmann–Loffler–Freytag reaction is proposed to involve 
initial N-radical generation followed by hydrogen abstraction through a 7-membered ring 
transition state. The new radical species (12), in turn, delivered cyclic carbonate 14. With this 
encouraging precedent, we sought to install a carbamate moiety to direct a C–H oxidation at the 
C-10 position in our molecule in a similar manner. 
 
In order to test the feasibility of this protocol on the decalin framework, we first prepared 
the simplified cis-decalin 23 (Scheme 4) to serve as a model compound. Beginning with a TiCl4-
assisted Diels–Alder reaction of 1-cyclohexene-1-carboxaldehyde (18) with 2-methyl-1,3-
butadiene (19), reduction of the resulting aldehyde 20 followed by carbamate formation afforded 
compound 22 smoothly. Following catalytic hydrogenation, the precursor for the Hofmann–
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Loffler–Freytag reaction (23) was obtained quantitatively in 2.2:1 dr. In the key test, subjecting 
the major isomer of 23 to the Baran conditions using N-bromide formation and subsequent 
photolization, we pleasingly obtained the desired carbonate 25 in 41% yield following a 
terminating treatment with Ag2CO3 and AcOH. 
 
Encouraged by this crucial result, we then set about applying this radical-based C–H 
oxidation to fully functionalized materials for the scaparvin terpenoids (Scheme 5). Common 
intermediate 3 was therefore treated with PhI(OTFA)2 and ethylene glycol, providing acetal 26. 
Next, a selective reduction of the ketone group in 26, followed by carbamate formation, 
successfully installed the directing group at the C-19 position. At this stage, given concerns of 
potential electrophilic additions involving the double bond under N-bromide formation 
conditions, an additional and alternative C–H oxidation precursor, epoxide 29 (dr = 1.4:1), was 




Unfortunately, following extensive attempts to tune reaction conditions (involving 
standard changes of solvents, temperature, reaction time, etc.), the proposed Hofmann–Loffler–
Freytag failed reaction to deliver the desired product (17, Scheme 6). Based on TLC analysis, the 
initial N-bromide formation step appeared to succeed, suggesting that N-radical 30 should be 
formed upon photo irradiation. However, the reaction ultimately afforded an uncharacterizable 
mixture of by-products in the end. Based on molecular models, the conformation of N-radical 
species might not be predisposed for success, as the productive conformer suffers from severe 
steric repulsion between the acetal group and the carbamate moiety. Given that the C5–C19 
single bond is free to rotate, the highly reactive N-radical might prefer to exist as conformer 31, 
which, in turn, could cause various side reactions either inter- or intramolecularly and thus 




Thus, we determined that achieving the needed C–H oxidation using C-19 functionality 
as a directing group is not likely to succeed, even with alternate protocols, based on the flexible 
molecular conformation of the framework in general terms. As a result, we needed to redesign 
our approach again to achieve a site-selective C-10 oxidation.  
 
4.3   C-10 Oxidation Using a Rigid Bridge System 
The key lesson we learned from the failed Hofmann–Loffler–Freytag strategy is that an 
effective directing group within our decalin framework should be conformationally locked. With 
this idea in mind, we revised our synthetic plan, aiming to construct the [2.2.1]-bridge system of 
the target first and then use functionality at the C-12 position to direct the C–H oxidation as 
shown in Scheme 7. The key concept here is that the C-12 moiety will be locked by the rigid 




To identify the optimal directing group, we sought to utilize a simplified [2.2.1]-bicyclic 
structure as an initial model (Scheme 8). As shown, this material took several steps to prepare. 
Starting from Diels–Alder product 33, subsequent double bond reduction, followed by a SmI2-
mediated Pinacol coupling2, afforded [2.2.1]-bicycle 35. This new material (35) was then 
oxidized to hydroxyl ketone 36 via Swern conditions3. It is worth mentioning that other 
oxidation conditions (such as Dess–Martin periodinane, IBX, TPAP/NMO, etc.) afforded 
oxidative cleavage products. After olefination of ketone 36 using a Wittig reaction,4 the resulting 
tertiary alcohol (37) was protected as a TBS ether to afford 38. Next, alcohol 39 was obtained as 
a mixture of diastereomers through a sequence of hydroboration and following oxidative work-
up. In addition to alcohol 39, compound 40 was also prepared as a potential C–H oxidation 




With both 39 and 40 in hand, we then examined the C–H oxidation chemistry (Scheme 9). 
After several failed attempts, we were pleased to find the oxy-radical generated from 39 under 
Suárez condition5 delivered C–H oxidation product 42 via a 1,5-hydrogen abstraction. Similarly, 
treatment of carboxylic acid 40 with the White-Chen catalyst [Fe(PDP)] and H2O2 also 
facilitated the desired tertiary C–H oxidation.6 Although the yields were low in both cases in 
numerical terms, the overall outcome is actually fairly good, considering that only one epimer 
(i.e. half of the starting material) satisfies the three-dimensional requirements for a productive 
transition state. In deciding how to press forward, we believed that the potential of lactone 
moiety in 44 for further functionalization would be a far superior approach, as we sought to use 




Encouraged by this crucial result, we then headed to C–H oxidation of fully 
functionalized materials for the scaparvin terpenoids, beginning with construction of the bridge 
system. As shown in Scheme 10, oxidative deprotection of the dithiolane moiety on common 
intermediate 3 using PhI(OTFA)2 provided ketoaldehyde 45. Surprisingly, upon treatment with 
SmI2, only ester migration product 46 was observed (a structure verified by X-ray 
crystallography), of which a plausible reaction pathway is showcased. The resulting ketyl radical 
anion 47, instead of adding to the ketone group, seemingly preferred to attack the sterically more 
accessible ester group. Once [1.2.3]-bicycle 48 is formed, it could quickly undergo a retro-aldol 





The solution to prevent this ester migration pathway proved very straightforward to 
achieve. Again starting from common intermediate 3, selective reduction of ester group followed 
by TIPS protection and oxidative deprotection of dithiolane group afforded ketoaldehyde 50 
smoothly. In this case, the ketone group is the only electrophilic site within the molecule, 




With this key bond now synthesized, the resultant 1,2-diol moiety was then oxidized to a 
hydroxy ketone using a standard Swern oxidation. After several unsuccessful attempts of 
olefinating the newly formed ketone, we identified that the Tebbe reagent could achieve the 
desired methylenation of this hindered ketone group.7 Next, hydroboration of that new alkene 52, 
followed by oxidative work-up, provided carboxylic acid 53 as a single diastereomer. In this 
substrate, the bulky TIPS group is crucial for regio- and facial-selectivity of the hydroboration 
step, which forces the borane species reacting from the opposite face. Other substrates with 
smaller functionalities at C-19 position, such as one with a TBS group, often resulted in complex 
mixtures of products and inferior yields of the desired carboxylic acid 53. Finally, the fully 
functionalized C–H oxidation precursor (54) was obtained through several straightforward 
protecting group manipulations.  
With 54 in hand, we first tested the directed C–H oxidation using the standard protocol 
reported by the White group.6 Adding 15 mol% of Fe(PDP) and 3 equivalents of H2O2 in three 
equal portions to a solution of 54 in acetonitrile over 45 min gave 55 in 31% yield. In the event, 
the carboxylic acid moiety again proved to be an effective directing group for C-10 oxidation, 
while the tri-substituted double bond was epoxidized as well. Although 55 could be reduced back 
to alkene 56 by using Cp2TiCl to extrude the epoxide oxygen atom, we felt it would be highly 
useful if a fully chemoselective C–H oxidation to deliver 56 in one step could be achieved, not 





In order to improve the directed C–H oxidation, we considered in greater depth the 
reaction pathways by which the oxidation could have occurred (Scheme 13). On one hand, when 
the carboxylic acid moiety coordinates to Fe(PDP), it should only facilitate an intramolecular 
hydrogen abstraction to afford the desired product 56. By contrast, any free iron-catalyst in the 
reaction media would be the likely culprit for catalyzing the epoxidation of olefin moiety. Based 
on this understanding of the mechanism, the key to suppress the epoxidation pathway is to limit 
the amount of free catalyst within the reaction mixture. 
 
A small screen of conditions revealed that both catalyst loading and addition method play 
an important role in controlling the C–H oxidation. The optimal conditions involved slow and 
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simultaneous addition of 2 mol% Fe(PDP) in CH3CN and 1.2 equivalent H2O2 in CH3CN over 1 
h using syringe pump into a solution of the substrate in CH3CN, providing the desired C–H 
oxidation product 56 in 43% yield along with 28% epoxide 55. Thus, although 56 could not be 
produced exclusively, overoxidation to 55 could be somewhat suppressed relative to our initial 
studies.  
 
Given the challenge of this chemical transformation, the overall yield of 63% is proved 
sufficient to move forward for further studies, noting that additional modifications to the 






4.4   Conclusion 
As detailed in the above sections, we have accomplished a site-selective C-H oxidation at 
C-10 position, affording compound 56 as an advanced intermediate for scaparvin terpenoids. It 
required a total of 9 steps from common intermediate 3, with key highlights of the developed 
approach being a SmI2-mediated Pinacol coupling and a directed C–H oxidation using the 
White-Chen catalyst under optimized conditions which achieved high chemoselectivity over a 
reactive and accessible trisubstituted alkene as denoted in Scheme 15.  
 
With sufficient quantities of advanced intermediate 56 prepared, we then proceeded to 
the final phase of our synthetic plan, the completion of total syntheses of scaparvin terpenoids, 
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4.6   Experimental Section 
General Methods: All reactions were carried out under an argon atmosphere with dry 
solvents under anhydrous conditions, unless otherwise stated. Dry methylene chloride (CH2Cl2), 
diethyl ether (Et2O), tetrahydrofuran (THF), benzene and toluene were obtained by passing 
commercially available pre-dried, oxygen-free formulations through activated alumina columns; 
triethylamine (Et3N) was distilled from KOH; dichloroethane (DCE), acetonitrile (CH3CN) and 
methanol (MeOH) were purchased in anhydrous form from Sigma-Aldrich and used as received. 
Yields refer to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated. Reagents were purchased at the highest commercial quality 
and used without further purification, unless otherwise stated. Reactions were magnetically 
stirred and monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. Merck 
silica gel plates (60F-254) using UV light and an aqueous solution of cerium ammonium sulfate 
and ammonium molybdate and heat as visualizing agents. Preparative TLC was carried out on 
0.50 mm E. Merck silica gel plates (60F-254). SiliCycle silica ge (60 A, academic grade, particle 
size 40-63 µm) was used for flash column chromatography. NMR spectra were recorded on 
Bruker DRX-300, DRX-400, DRX-500 and DRX-700 instruments and calibrated using residual 
undeuterated solvent as an internal reference. The following abbreviations are used to explain 
multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = 
apparent. IR spectra were recorded on a Perkin-Elmer Spectrum Two FT-IR spectrometer. High 
resolution mass spectra (HRMS) were recorded in the Columbia University Mass Spectral Core 
facility on a JOEL HX110 mass spectrometer using FAB (Fast Atom Bombardment). 
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Diol 51. To a solution of common intermediate (3, 8.0 g, 22.6 mmol, 1.0 equiv) in THF 
(50 mL) at –78 °C was added a solution of KHMDS in toluene (0.5 M, 72.3 mL, 1.6 equiv). The 
stirred reaction was then warmed to 0 °C for 30 min. A solution of DIBAL-H in toluene (1.0 M, 
72.3 mL, 3.2 equiv) was added dropwise into the yellowish solution at the same temperature. 
Then, the reaction contents were slowly warmed to 23 °C over 16 h. Upon completion 
(determined by TLC analysis), the reaction was cooled to 0 °C and slowly quenched by a 
mixture of saturated aqueous NH4Cl (50 mL) and saturated aqueous Rochelle’s Salt (50 mL). 
After stirring for an additional 2 h at 23 °C, the reaction contents were then transferred to a 
separatory funnel, diluting with EtOAc (100 mL). The organic layer was separated and the 
aqueous layer was extracted with EtOAc (3  50 mL). The organic layers were combined, 
washed by saturated aqueous NaCl (50 mL), dried with MgSO4, filtered and concentrated. The 
resulting crude product was directly used for the following step. 
The crude alcohol product was dissolved in CH2Cl2 (500 mL) and cooled to 0 °C. 2,6-
Lutidine (10.4 mL, 90.4 mmol, 4.0 equiv) was added into the resulting solution, followed by 
slow addition of TIPSOTf (12.1 mL, 42.5 mmol, 2.0 equiv). After 10 min, the ice-water bath was 
removed and the reaction mixture was allowed to warm to 23 °C for 16 h. Then, 10 mL MeOH 
was added into the reaction contents, which was concentrated to a viscous oil and further diluted 
with MeOH (50 mL) at 0 °C. PhI(OTFA)2 (21.3g 49.7 mmol, 2.2 equiv) was added in one 
portion, and the resulting white mixture was further stirred for 6 h at 23 °C. Upon completion, 
the reaction was diluted with THF (500 mL) and quenched by 2 M aqueous HCl solution (200 
mL) and further stirred for 10 h at this temperature. The reaction contents were then transferred 
to a separatory funnel, diluting with EtOAc (500 mL) and hexanes (500 mL). The organic layer 
was separated and the aqueous layer was extracted with EtOAc (3  400 mL). The organic layers 
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were combined, washed with saturated aqueous NaHCO3 solution (500 mL), dried with MgSO4, 
filtered and concentrated. The resulting crude product was purified by flash column 
chromatography (silica gel, hexanes/EtOAc, 50:1 to 10:1) to give ketoaldehyde 50 (5.79 g, 63% 
yield over two steps) as a yellowish oil. 
 Next, this product (50, 5.79 g, 14.2 mmol, 1.0 equiv) was dissolved in THF (500 mL) 
and cooled to 0 °C. A freshly made solution of SmI2 in THF (0.1 M, 71.0 mmol, 710 mL, 5.0 
equiv) was added dropwise through a cannula. After 10 min, the ice-water bath was removed and 
the reaction mixture was allowed to warm to 23 °C for 16 h. Upon completion, the reaction 
contents were quenched by saturated aqueous Rochelle’s Salt (500 mL) and transferred to a 
separatory funnel. The organic layer was separated and the aqueous layer was extracted with 
EtOAc (3  500 mL). The organic layers were combined, washed by saturated aqueous NaCl 
(500 mL), dried with MgSO4, filtered and concentrated. The resulting crude product was purified 
by flash column chromatography (silica gel, hexanes/EtOAc, 10:1 to 4:1) to give diol 51 (4.75 g, 
82% yield) as a white solid. 51: 1H NMR (400 MHz, CDCl3) δ 5.79 (m, 1 H), 3.94 (d, J = 9.8 Hz, 
1 H), 3.72 (s, 1 H), 3.61 (d, J = 9.8 Hz, 1 H), 2.31 (m, 1 H), 2.07–1.91 (m, 2 H), 2.02 (br, 3 H), 
1.73–1.52 (m, 3 H), 1.48 (m, 1 H), 1.42 (m, 1 H), 1.16–0.98 (m, 27 H); 13C NMR (100 MHz, 
CDCl3) δ 139.1, 127.3, 85.8, 83.5, 73.2, 47.0, 46.7, 45.6, 38.1, 35.8, 23.0, 22.8, 21.2, 18.0, 17.9, 
16.5, 16.3, 11.6. 
Carboxylic acid 53. To a solution of oxalyl chloride (0.60 mL, 6.80 mmol, 1.5 equiv) in 
CH2Cl2 (50 mL) at –78 °C was added DMSO (1.65 mL, 22.7 mmol, 5.0 equiv) dropwise. After 
stirring for 30 min, a solution of diol 51 (1.85 g, 4.53 mmol, 1.0 equiv) in CH2Cl2 (100 mL) was 
slowly added at –78 °C. The reaction solution was further stirred at –78 °C for 1 h, whereafter 
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Et3N (6.5 mL, 45.3 mmol, 10 equiv) was added at the same temperature, and the reaction 
contents were slowly warmed to 23 °C over 6 h. The yellow solution was then quenched by 
water (100 mL) and transferred to a separatory funnel. The organic layer was separated and the 
aqueous layer was extracted with CH2Cl2 (3  50 mL). The organic layers were combined, dried 
with MgSO4, filtered and concentrated. The resulting crude product was purified by flash column 
chromatography (silica gel, hexanes/EtOAc, 30:1 to 10:1) to give the resulting ketone (1.64 g, 89% 
yield) as a yellowish oil.  
Next, this ketone product (1.73 g, 4.26 mmol, 1.0 equiv) was dissolved in THF (100 mL) 
and cooled to 0 °C. Pyridine (1.6 mL, 21.3 mmol, 5.0 equiv) followed by a solution of Tebbe 
reagent in toluene (0.5 M, 21.3 mL, 5.0 equiv) was added dropwise. After 10 min, the ice-water 
bath was removed and the dark-brown solution was heated to 50 °C for 16 h. Upon completion 
(determined by TLC analysis), the reaction contents were quenched by saturated aqueous 
Rochelle’s Salt (500 mL) and transferred to a separatory funnel. The organic layer was separated 
and the aqueous layer was extracted with EtOAc (3  50 mL). The organic layers were combined, 
washed by saturated aqueous NaCl (500 mL), dried with MgSO4, filtered and concentrated. The 
resulting crude product was purified by flash column chromatography (silica gel, hexanes/EtOAc, 
50:1 to 30:1) to give alkene 52 (1.00 g, 58% yield) as a colorless oil. 
To a solution of alkene 52 (1.00 g, 2.47 mmol, 1.0 equiv) in THF (50 mL) at 0 °C was 
added borane THF complex solution (1.0 M, 6.18 mmol, 2.5 equiv). After 10 min, the ice-water 
bath was removed and the reaction solution was heated to 35 °C for 3 h. Upon completion, the 
reaction was cooled to 0 °C and quenched by water (5 mL), followed by addition of NaBO3-H2O 
(494 mg, 4.94 mmol, 2.0 equiv) in one portion. After stirring at 23 °C for 5 h, the reaction 
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mixture was diluted with tBuOH (50 mL) and 2-Methyl-2-butene (20 mL). Next, TEMPO (385 
mg, 2.47 mmol, 1.0 equiv) followed by a solution of NaClO2 (4.47 g, 49.44 mmol, 20 equiv) and 
NaH2PO4-2H2O (7.71 g, 49.4 mmol, 20 equiv) in water (40 mL) was added into reaction mixture 
at 0 °C. After 10 min, the ice-water bath was removed and the reaction mixture was allowed to 
warm to 23 °C for 6 h. Upon completion, the reaction contents were diluted with water (50 mL) 
and transferred to a separatory funnel. The organic layer was separated and the aqueous layer 
was extracted with EtOAc (3  50 mL). The organic layers were combined, washed by saturated 
aqueous NaCl (50 mL), dried with MgSO4, filtered and concentrated. The resulting crude 
product was purified by flash column chromatography (silica gel, hexanes/EtOAc, 20:1 to 10:1, 
with 0.1% AcOH) to give carboxylic acid 53 (702 mg, 65% yield) as a colorless oil. 53: 1H NMR 
(400 MHz, CDCl3) δ 9.93 (br, 1 H), 6.09 (br, 1 H), 5.79 (m, 1 H), 3.98 (d, J = 10.4 Hz, 1 H), 
3.58 (d, J = 10.4 Hz, 1 H), 2.33 (s, 1 H), 2.07 (br, 3 H), 2.06–1.92 (m, 3 H), 1.86 (m, 1 H), 1.74–
1.53 (m, 4 H), 1.29 (s, 3 H), 1.15–0.98 (m, 24 H); 13C NMR (100 MHz, CDCl3) δ 173.1, 139.1, 
127.5, 88.0, 73.2, 61.4, 48.6, 46.7, 46.4, 41.2, 40.8, 23.5, 22.9, 17.8, 17.7, 17.4, 16.9, 11.6. 
 
Carboxylic acid 54. To a solution of carboxylic acid 53 (538 mg, 1.23 mmol, 1.0 equiv) 
in THF (10 mL) at 0 °C was added a solution of TBAF in THF (1.0 M, 1.35 mL, 1.1 equiv). 
After 10 min, the ice-water bath was removed and the reaction mixture was allowed to warm to 
23 °C for 4 h. The resultant solution was slowly transferred into a vigorously-stirred solution of 
acetic anhydride (0.26 mL, 2.71 mmol, 2.2 equiv) and DMAP (480 mg, 3.94 mmol, 3.2 equiv) in 
THF (10 mL) at 0 °C through a cannula. After stirring at 0 °C for an additional 30 min, the 
reaction was quenched by 10% aqueous AcOH solution (20 mL) and further stirred for 30 min at 
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this temperature. The reaction contents were then transferred to a separatory funnel, diluting with 
EtOAc (20 mL) and hexanes (20 mL). The organic layer was separated and the aqueous layer 
was extracted with EtOAc (3  30 mL). The organic layers were combined, dried with MgSO4, 
filtered and concentrated. The resulting crude product was purified by flash column 
chromatography (silica gel, hexanes/EtOAc, 3:1 to 1:1, with 0.1% AcOH) to give acetate product 
37 (337 mg, 85% yield) as a colorless oil.  
Next, this acetate product (337 mg, 1.05 mmol, 1.0 equiv) was dissolved in CH2Cl2 (10 
mL) and cooled to 0 °C. 2,6-Lutidine (0.36 mL, 3.15 mmol, 3.0 equiv) followed by TESOTf 
(0.47 mL, 2.10 mmol, 2.0 equiv) was added dropwise. After 10 min, the ice-water bath was 
removed and the reaction was allowed to warm to 23 °C for 5 h. Upon completion (determined 
by TLC analysis), the reaction contents were quenched by MeOH (1 mL) and AcOH (1 mL) and 
further stirred at 23 °C for 2 h. The reaction contents were then transferred to a separatory funnel, 
diluting with EtOAc (40 mL), hexanes (40 mL) and water (100 mL). The organic layer was 
separated and the aqueous layer was extracted with EtOAc (3  50 mL). The organic layers were 
combined, dried with MgSO4, filtered and concentrated. The resulting crude product was 
purified by flash column chromatography (silica gel, hexanes/EtOAc, 5:1 to 3:1, with 0.1% 
AcOH) to give carboxylic acid 54 (440 mg, 96% yield) as a white solid. 54: 1H NMR (400 MHz, 
CDCl3) δ 5.70 (br, 1 H), 4.46 (d, J = 11.5 Hz, 1 H), 3.94 (d, J = 11.5 Hz, 1 H), 2.81 (t, J = 9.2 Hz, 
1 H), 2.38 (s, 1 H), 2.05–1.90 (m, 2 H), 1.97 (s, 3 H), 1.82 (m, 1 H), 1.77 (br, 3 H), 1.74–1.65 (m, 
2 H), 1.60 (m, 1 H), 1.31 (m, 1 H), 1.21 (s, 3 H), 1.05 (d, J = 7.8 Hz, 3 H), 0.98 (m, 9 H), 0.73 
(m, 6 H). 
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Advanced intermediate 56. To a suspension of carboxylic acid 54 (56.2 mg, 0.128 
mmol, 1.0 equiv) in CH3CN (3 mL) at 10 
oC was added a solution of Fe(PDP) (2.4 mg, 2 mol%) 
in CH3CN (3 mL) and a solution of H2O2 (30%, 17 uL, 0.154 mmol, 1.2 equiv) in CH3CN (3 mL) 
simultaneously over 1 h using syringe pump. After stirring for an additional 10 min at 23 °C, the 
yellowish solution was quenched by saturated aqueous Na2SO3 solution (20 mL) and diluted 
with Et2O (20 mL). The reaction contents were then transferred to a separatory funnel, diluting 
with hexanes (20 mL) and water (20 mL). The organic layer was separated and the aqueous layer 
was extracted with Et2O (3  20 mL). The organic layers were combined, washed by saturated 
aqueous NaCl (20 mL), dried with MgSO4, filtered and concentrated. The resulting crude 
product was purified by flash column chromatography (silica gel, hexanes/EtOAc, 10:1 to 4:1) to 
give advanced intermediate 56 (23.9 mg, 43% yield) and epoxide 55 (16.2 mg, 28% yield). 56: 
1H NMR (400 MHz, CDCl3) δ 5.61 (br, 1 H), 4.63 (d, J = 12.4 Hz, 1 H), 3.90 (d, J = 12.4 Hz, 1 
H), 2.51 (s, 1 H), 2.27–2.14 (m, 2 H), 2.14–2.01 (m, 3 H), 1.99 (s, 3 H), 1.82 (br, 3 H), 1.82 (m, 
1 H), 1.69 (m, 1 H), 1.10 (s, 3 H), 0.97 (m, 12 H), 0.67 (m, 6 H); 13C NMR (100 MHz, CDCl3) δ 
174.4, 170.2, 132.8, 126.9, 94.3, 87.3, 66.7, 63.2, 62.3, 52.2, 39.5, 36.3, 22.2, 21.0, 20.7, 20.0, 



























































































INSTALLATION OF THE FURAN MOIETY TO ACHIEVE  











5.1   Introduction 
With a reliable synthetic route towards advanced intermediate 1, we then turned our 
attention to the final tailoring needed to achieve total syntheses of the scaparvin terpenoids 
(Scheme 1). The two key remaining tasks are the installation of the 3-furanyl moiety and 
intramolecular formation of ketal, events which could potentially be achieved in a single pot. 
This chapter will describe the final stages leading to a completed total synthesis of scaparvin C 
as well as a detailed evolution of our approach towards scaparvin A. 
 
 
5.2   Total Synthesis of Scaparvin C 
Retrosynthetically, scaparvin C (3) can be viewed as the thermodynamic product of 
transketalization from compound 5, a material which in turn could arise from lactone 6 via the 
nucleophilic addition of 3-furyllithium. Lactone 6 could be then traced back to 7 through several 
straightforward chemical transformations. Finally, compound 7 could be obtained from a retro-




In the forward sense, treating advanced intermediate 1 with TBAF in THF succeeded in 
deprotecting the tertiary TES ether selectively, with the resulting anion (8) converting to 
ketoester 7 quantitatively with prolonged reaction times. Surprisingly, mixing 7 with NaBH4 in 
MeOH not only reduced the ketone group, but also deprotected the acetate group (likely due to 
the basic reaction condition). The resulting 1,3-diol 9 was then protected in situ as the base-




Our initial attempts to install the furan moiety focused on the nucleophilic addition of 3-
furyllithium (Scheme 4). Monoaddition to lactone 6 at low temperature (<–40 °C) seemed 
promising to deliver hemiketal 5. Unfortunately, despite being effective on simple five-
membered lactones, a screen of various conditions (temperature, Lewis acid, solvent, etc.) 
consistently afforded no conversion at low temperature (<–20 °C) and occasionally the formation 
of several uncharacterizable by-products at high temperature (>23 °C). In addition, the 
hemiacetal variant (10), which was obtained from DIBAL-H reduction of 6, showed a similar 
reactivity profile as lactone 6. Our analysis of these outcomes was that the hindered nature of the 
lactone group renders it exceptionally unreactive, likely because the preferred attack trajectory 
(Bürgi–Dunitz angle) may be sterically obstructed by the presence of the C-20 methyl, a domain 




In light of these consistent failures, we contemplated installing the furan moiety through a 
cross-coupling strategy. Specifically, we hoped that triflate 12, derived from lactone 6, could 
couple with 3-furyltin compound 14 via a Stille coupling,1 thus resulting in the formal 
installation of furan moiety and affording a new material whose oxidation state is consistent with 
that of the final targets. 
 
Executing this idea started by subjecting lactone 6 to KHMDS, followed by the addition 
of Comin’s reagent2 at low temperature (–78 °C). Although the resulting vinyl triflate 12 proved 
to be very labile to mildly acidic conditions (it slowly decomposed on silica gel, for example), it 
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was stable (at least for 1 d) under neutral or basic condition to utilize in the subsequent Stille 
coupling reaction. For this key event, after a small amount of screening, we discovered that the 
Nicolaou conditions used in their syntheses of maitotoxin fragments gave the best results.3  
 
In this operation, the Pd-catalyzed cross-coupling of enol triflate 12 and 3-furyltin 14 was 
carried out in the presence of CuCl (2.0 equiv) and K2CO3 (2.0 equiv) in THF at 25 °C, affording 
vinyl furan 13 after 2 h of reaction time. Upon acidic work-up, the proposed transketalization 
occurred cleanly using aqueous HCl in THF/MeOH at room temperature, thus completing our 
total synthesis of scaparvin C (3). The spectral properties of synthetic 3 fully agree with the 
naturally isolated material reported by Lou,4 as shown in Table 1 and 2. 
Table 1. Comparison of 1H NMR shifts (δ) of synthetic 3 and natural 3. 
Natural 3 Synthetic 3 
7.46 (br, 1 H) 7.45 (br, 1 H) 
7.33 (t, J = 1.5 Hz, 1 H) 7.33 (t, J = 1.7 Hz, 1 H) 
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6.39 (br, 1 H) 6.39 (br, 1 H) 
6.06 (br, 1 H) 6.06 (br, 1 H) 
4.20 (d, J = 12.8 Hz, 1 H) 4.20 (d, J = 12.7 Hz, 1 H) 
3.89 (d, J = 12.8 Hz, 1 H) 3.89 (d, J = 12.7 Hz, 1 H) 
3.45 (t, J = 7.0 Hz, 1 H) 3.45 (dt, J = 1.8, 6.8 Hz, 1 H) 
2.41 (d, J = 14.1 Hz, 1 H) 2.41 (d, J = 14.0 Hz, 1 H) 
2.33 (m, 1 H), 2.27 (ddq, J = 4.2, 6.8, 10.8 Hz, 1 H) 2.38–2.20 (m, 2 H) 
2.21 (ddd, J = 4.2, 6.5, 14.3 Hz, 1 H) 2.12 (m, 1 H) 
2.08 (d, J = 14.1 Hz, 1 H) 2.08 (d, J = 14.0 Hz, 1 H) 
2.06 (m, 1 H) 2.06 (m, 1 H) 
1.93 (dd, J = 6.4, 13.6 Hz, 1 H) 1.94 (m, 1 H) 
1.82 (br, 3 H) 1.82 (br, 3 H) 
1.73 (ddd, J = 6.7, 11.8, 13.4 Hz, 1 H) 1.73 (m, 1 H) 
1.47 (ddd, J = 7.4, 10.8, 14.3 Hz, 1 H) 1.47 (m, 1 H) 
1.07 (s, 3 H) 1.07 (s, 3 H) 
1.07 (d, J = 6.8 Hz, 3 H) 1.06 (d, J = 7.0 Hz, 3 H) 
 
Table 2. Comparison of 1C NMR shifts (δ) of synthetic 3 and natural 3. 























Globally, we had succeeded in preparing scaparvin C (3) in 16 steps from Rawal’s diene. 
With this exciting result in hand, we next set our sights on achieving a total synthesis of 
scaparvin A with the [2.2.1]-bicycle structure needing to remain intact. 
 
5.3   Studies towards the Total Synthesis of Scaparvin A 
Despite the success of the Stille coupling strategy towards scaparvin C (3) noted above, 
its use for scaparvin A in the form of vinyl triflate 15 with its bridge system intact was 
anticipated to be hard, if not impossible, to synthesize, thus preventing the use of this approach 
to access of scaparvin A (1). In addition, similar to the previous results described above in terms 
of nucleophilic additions of 3-furyllithium, all attempts to achieve this process with 1 and other 
protected variants of this key compound failed to deliver the desired hemiketal 17. As a result, 




As shown in Scheme 8, if a radical-generating group could be attached to the C-12 bridge 
head position, the resulting radical (19) could potentially attack a radical acceptor such as ,-
unsaturated lactone 20 and give 21. Although not a direct formation of the furyl ring system, if 
this coupling could be achieved it was anticipated that the furan moiety in scaparvin A (2) could 
be derived readily through several straightforward reactions. Literature precedents supported this 
radical-based coupling idea in general terms, as there were a few examples of productive 
bridgehead radicals, particularly as demonstrated by the Inoue group at the University of Tokyo.5 
While these precedents were certainly encouraging, however, none matched our exact system, 
and we uncertain just what the stability and electronic profile our bridgehead radical would have 
if it could be formed.  
 
Given our concerns, we felt that the most prudent course of action was to identify an 
initial model for the desired transformation. The most readily accessible and comparable model 
compound in our opinion was 24. This material was prepared in two steps through mono-
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reduction of commercially available diketone 22 and subsequent thiocarbonate formation. 
Pleasingly, treatment of 24 with 5 equivalents of radical acceptor 20 using Et3B and O2 as the 
radical initiators at room temperature, afforded the desired coupling product 26 in 93% yield. 
Finally, formation of the furan moiety was accomplished through a sequence involving oxidative 
selenoxide elimination6 and DIBAL-H reduction. 
 
Encouraged by this result, we set about applying these conditions to fully functionalized 
materials for scaparvin A (2). Thus, advanced intermediate 1 was therefore hydrolyzed under 
neutral condition of Me3SnOH,
7 affording translactonization product 29. After installing the 
thiocarbonate group, radical 19 was generated by using Et3B and O2 as radical initiators just as 
described earlier. However, instead of forming lactone 21 through radical addition, only six-
membered lactone 32 was observed. Evidently, the bridge head radical 19 in this case is not 
stable enough for the intermolecular addition, but prefers to break the cage structure in what 
would then release of ring strain. Because it is an intramolecular process, we felt that this 




With this failure, we believe that future efforts should revisit the original nucleophilic 
addition approach, but do so using oxonium ion 35 as the electrophile (Scheme 11). If acetal 33 
could be synthesized from advanced intermediate 1, treatment with 3-furyltitanium reagent may 
give oxonium ion 35 and, in turn, facilitate the nucleophilic addition of furan moiety. This mode 
of nucleophilic addition is believed to be promising for two reasons. First, the oxonium ion is 
more electrophilic than the previously used lactone, and thus should be more reactive towards 
addition of furan moiety. Second, and which is more important, the preferred attack trajectory of 
the oxonium ion (i.e. the Bürgi–Dunitz angle) is different from the lactone counterpart and would 
appear to not be sterically obstructed by the C-20 methyl. If true, a subsequent benzylic 





5.4   Conclusion 
Globally, through the work delineated in this chapter, the total synthesis of scaparvin C (3) 
has been accomplished in 16 steps from Rawal’s diene (Scheme 12). Also, we are confident that 
an effective synthetic solution for scaparvin A (2) will be available in the near future. From these 
initial advances, an effective course for accessing the full diversity represented by clerodane 
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5.6   Experimental Section 
General Methods: All reactions were carried out under an argon atmosphere with dry 
solvents under anhydrous conditions, unless otherwise stated. Dry methylene chloride (CH2Cl2), 
diethyl ether (Et2O), tetrahydrofuran (THF), benzene and toluene were obtained by passing 
commercially available pre-dried, oxygen-free formulations through activated alumina columns; 
triethylamine (Et3N) was distilled from KOH; dichloroethane (DCE), acetonitrile (CH3CN) and 
methanol (MeOH) were purchased in anhydrous form from Sigma-Aldrich and used as received. 
Yields refer to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated. Reagents were purchased at the highest commercial quality 
and used without further purification, unless otherwise stated. Reactions were magnetically 
stirred and monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. Merck 
silica gel plates (60F-254) using UV light and an aqueous solution of cerium ammonium sulfate 
and ammonium molybdate and heat as visualizing agents. Preparative TLC was carried out on 
0.50 mm E. Merck silica gel plates (60F-254). SiliCycle silica ge (60 A, academic grade, particle 
size 40-63 µm) was used for flash column chromatography. NMR spectra were recorded on 
Bruker DRX-300, DRX-400, DRX-500 and DRX-700 instruments and calibrated using residual 
undeuterated solvent as an internal reference. The following abbreviations are used to explain 
multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = 
apparent. IR spectra were recorded on a Perkin-Elmer Spectrum Two FT-IR spectrometer. High 
resolution mass spectra (HRMS) were recorded in the Columbia University Mass Spectral Core 
facility on a JOEL HX110 mass spectrometer using FAB (Fast Atom Bombardment). 
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Lactone 6. To a solution of advanced intermediate 1 (20.2 mg, 0.0464 mmol, 1.0 equiv) 
in THF (2 mL) at 0 °C was added a solution of TBAF in THF (1.0 M, 0.070 mL, 1.5 equiv). The 
reaction contents were then concentrated in vacuum and diluted with MeOH (2 mL). NaBH4 (8.8 
mg, 0.232 mmol, 5.0 equiv) was added in three portions into the reaction solution at 0 °C over 1 
h. Then, the reaction contents were slowly warmed to 23 °C over 10 h. Upon full conversion to 
the resultant diol (determined by TLC analysis), the reaction mixture was concentrated again and 
diluted with 2,2-dimethoxypropane (10 mL). pTSA-H2O (265 mg, 1.39 mmol, 30.0 equiv) was 
added in one portion to the solution at 23 °C. After stirring for an additional 2 h at 23 °C, the 
reaction was quenched by saturated aqueous NaHCO3 solution (20 mL). The reaction contents 
were then transferred to a separatory funnel, diluting with EtOAc (10 mL) and hexanes (10 mL).  
The organic layer was separated and the aqueous layer was extracted with EtOAc (3  10 mL). 
The organic layers were combined, washed by saturated aqueous NaCl (10 mL), dried with 
MgSO4, filtered and concentrated. The resulting crude product was purified by flash column 
chromatography (silica gel, hexanes/EtOAc, 20:1 to 6:1) to give lactone 6 (13.2 mg, 89% yield) 
as a white solid. 6: 1H NMR (400 MHz, CDCl3) δ 5.46 (br, 1 H), 4.31 (d, J = 10.6 Hz, 1 H), 4.22 
(dd, J = 3.3, 11.2 Hz, 1 H), 3.62 (d, J = 10.6 Hz, 1 H), 2.46 (d, J = 17.2 Hz, 1 H), 2.24 (d, J = 
17.2 Hz, 1 H), 2.29–2.14 (m, 2 H), 2.10 (br, 3 H), 1.98–1.71 (m, 3 H), 1.69–1.45 (m, 2 H), 1.45 
(s, 3 H), 1.36 (s, 3 H), 0.99 (s, 3 H), 0.85 (d, J = 6.7 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
175.1, 137.2, 125.9, 99.0, 91.8, 70.6, 70.5, 46.8, 42.7, 42.3, 37.3, 33.1, 29.3, 25.6, 24.9, 24.3, 
19.1, 16.7, 14.0. 
Scaparvin C (3). To a solution of lactone 6 (3.5 mg, 0.0109 mmol, 1.0 equiv) in THF (2 
mL) at –78 °C was added a solution of KHMDS in toluene (0.5 M, 0.066 mL, 3.0 equiv). After 
stirring at –78 °C for 45 min, a solution of Comin’s reagent (17.0 mg, 0.0436 mmol, 4.0 equiv) 
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in THF (2 mL) was added dropwise at the same temperature. After stirring for an additional 1 h 
at –78 °C, the reaction was quenched by saturated aqueous NaHCO3 solution (5 mL) at –78 °C, 
whereafter the reaction mixture was slowly warmed to 23 °C over 30 min. The reaction contents 
were then transferred to a separatory funnel, diluting with EtOAc (5 mL) and hexanes (5 mL).  
The organic layer was separated and the aqueous layer was extracted with EtOAc (3  5 mL). 
The organic layers were combined, dried with Na2SO4, filtered and concentrated. The resulting 
crude product was roughly purified by a quick flash column chromatography (silica gel, 
hexanes/EtOAc, 10:1) to give triflate 12 as a yellowish foam. This material was immediately 
carried forward in the following reaction. 
Triflate 12 was then dissolved in THF (1 mL) at 23 °C. Then, a solution of 3-furyltin 
compound 14 (7.8 mg, 0.0218 mmol, 2.0 equiv) in THF was added to the resultant solution, 
followed by consecutive additions of CuCl (2.2 mg, 0.0218 mmol, 2.0 equiv), K2CO3 (3.0 mg, 
0.0218 mmol, 2.0 equiv) and Pd(PPh3)4 (1.3 mg, 0.00109 mmol, 10 mol%). The reaction mixture 
quickly turned brown over 10 min. After stirring at 23 °C for 2 h, the reaction was quenched by 
~1.25 M HCl in MeOH (1 mL). The reaction mixture was vigorously stirred at 23 °C for 10 h, 
whereafter the reaction contents were transferred to a separatory funnel, diluting with Et2O (5 
mL) and aqueous NaHCO3 solution (5 mL). The organic layer was separated and the aqueous 
layer was extracted with Et2O (3  5 mL). The organic layers were combined, washed with 5% 
aqueous KF solution (10 mL), dried with MgSO4, filtered and concentrated. The resulting crude 
product was purified by flash column chromatography (silica gel, hexanes/EtOAc, 10:1 to 4:1) to 
give scaparvin C (3) (1.9 mg, 53% yield over two steps) as white solid. 3: 1H NMR (400 MHz, 
CDCl3) δ 7.45 (br, 1 H), 7.33 (t, J = 1.7 Hz, 1 H), 6.39 (br, 1 H), 6.06 (br, 1 H), 4.20 (d, J = 12.7 
Hz, 1 H), 3.89 (d, J = 12.7 Hz, 1 H), 3.45 (dt, J = 1.8, 6.8 Hz, 1 H), 2.41 (d, J = 14.0 Hz, 1 H), 
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2.38–2.20 (m, 2 H), 2.12 (m, 1 H), 2.08 (d, J = 14.0 Hz, 1 H), 2.06 (m, 1 H), 1.94 (m, 1 H), 1.82 
(br, 3 H), 1.73 (m, 1 H), 1.47 (m, 1 H), 1.07 (s, 3 H), 1.06 (d, J = 7.0 Hz, 3 H); 13C NMR (175 
MHz, CDCl3) δ 142.9, 139.5, 131.2, 130.8, 127.3, 108.4, 101.5, 84.8, 67.6, 65.3, 55.3, 45.5, 45.0, 


























    
120 
 
 
 
